Exhibit
      31.1





**CERTIFICATION
      OF PRINCIPAL EXECUTIVE AND OFFICERS**


**PURSUANT
      TO RULES 13A-14 AND 15D-14**


**OF
      THE SECURITIES AND EXCHANGE ACT OF 1934**








I,
      Nelson
      Liao, Chief Executive Officer, certify that:





1.
      I have
      reviewed this amended quarterly report on Form 10-QSB/A of AOB Biotech,
      Inc.;





2.
      Based
      on my knowledge, this amended quarterly report does not contain any untrue
      statements of a material fact or omit to state a material fact necessary to
      make
      the statements made, in light of the circumstances under which such statements
      were made, not misleading with respect to the period covered by this quarterly
      report;





3.
      Based
      on my knowledge, the financial statements, and other financial information
      included in this amended quarterly report, fairly present in all material
      respects the financial condition, results of operations and cash flows of the
      registrant as of, and for, the periods presented in this amended quarterly
      report;





4.
      The
      registrant's other certifying officers and I are responsible for establishing
      and maintaining disclosure controls and procedures (as defined in Exchange
      Act
      Rules 13a-14 and 15d-14) for the registrant and we have:





a)
            designed
                such disclosure controls and procedures to ensure that material
                information relating to the registrant, including its consolidated
                subsidiaries, is made known to us by others within those entities,
                particularly during the period in which this amended quarterly report
                is
                being prepared;





b)
            evaluated
                the effectiveness of the registrant's disclosure controls and procedures
                as of a date within 90 days prior to the filing date of this amended
                quarterly report (the "Evaluation Date");
                and





c)
            presented
                in this amended quarterly report our conclusions about the effectiveness
                of the disclosure controls and procedures based on our evaluation
                as of
                the Evaluation Date;





5.
      The
      registrant's other certifying officers and I have disclosed, based on our most
      recent evaluation, to the registrant's auditors and the registrant's board
      of
      directors (or persons performing the equivalent functions):





a)
            all
                significant deficiencies in the design or operation of internal controls
                which could adversely affect the registrant's ability to record,
                process,
                summarize and report financial data and have identified for the
                registrant's auditors any material weaknesses in internal controls;
                and





b)
            any
                fraud, whether or not material, that involves management or other
                employees who have a significant role in the registrant's internal
                controls; and





6.
      The
      registrant's other certifying officers and I have indicated in this amended
      quarterly report whether or not there were significant changes in internal
      controls or in other factors that could significantly affect internal controls
      subsequent to the date or our most recent evaluation, including any corrective
      actions with regard to significant deficiencies and material
      weaknesses.









February
                1, 2007
            ***/s/
                Nelson Liao****Nelson
                Liao**Chief
                Executive Officer*